COVID-19

As information changed rapidly, pharmacists quickly adapted their strategies by leveraging social media for updates to patients.

Tom DePietro, PharmD, owner of DePietro's Pharmacy, highlights the deep community connections that enabled the pharmacy to respond effectively to the pandemic.

Jade Ranger, co-owner and pharmacist of the Prescription Shoppe, discusses how her pharmacy put patients first during the COVID-19 pandemic.

Jade Ranger, PharmD, co-owner and pharmacist at the Prescription Shoppe, discussed administering vaccines during the COVID-19 pandemic.

Jeffery Goad, PharmD, MPH, president of the National Foundation for Infectious Diseases, reflects on the COVID-19 pandemic 5 years later.

The most commonly reported symptoms of long COVID include neurological, muscular, respiratory, and psychological.

Ensitrelvir demonstrated a 67% relative risk reduction of developing symptomatic COVID-19 in household contact patients.

COVID-19 vaccination before a SARS-CoV-2 infection was associated with a 75% reduced likelihood of long COVID symptoms that impact daily functioning among patients between the ages of 5 and 17 years.

Researchers compared hospitalization and mortality outcomes of older adults with and without restricted access to nirmatrelvir-ritonavir.

The increased risk of symptoms only includes respiratory-related symptoms or brain fog.

The next-gen molecular Metrix was given emergency use authorization for its ability to test for SARS-CoV-2 and influenza A and B viruses.

In their exploration of 2 separate respiratory virus seasons, researchers examined the severity of illness for SARS-CoV-2, influenza, and respiratory syncytial virus.

Researchers compared simultaneous and sequential administration of the mRNA COVID-19 and inactivated influenza vaccines.

A study found that of 110 patients with long COVID, over half reported decreased QOL due to pain, discomfort, anxiety, or depression.

Using the DASH Rapid PCR System, providers can yield test results in under 1 minute of hands-on time.

Researchers explored ideas of simplifying the vaccination process to yield higher rates of adult immunization, similar to that of the COVID-19 pandemic.

Check out this list of our top 5 most read COVID-19 stories from the year 2024.

Authors concluded that that the benefit of the vaccine in preventing long COVID is due mainly to the fact it mitigates the risk of infection.

The effectiveness of remdesivir was consistent among patients who received any form of supplemental oxygen and across all age groups in the study.

The MOVe-NOW study will assess the investigational oral antiviral using a different formulation than what is currently approved under an emergency use authorization.

The higher burden of neurological symptoms among younger and middle-aged adults translated to worse subjective quality of life, according to a recent study.

A recent study showed that cognitive behavioral therapy could help reduce fatigue and improve concentration with moderate certainty.

Catch up on important COVID-19 news from November 2024.

Individuals who received tailored text message reminders about receiving a COVID-19 booster vaccine were more likely to get it.

Public health and infectious disease experts offered their perspectives on the 2024 US bird flu outbreak and its potential of becoming a greater public health crisis.

“[O]ur data do not support the hypothesis that early COVID resulted in more significant structural or electrical cardiac remodeling that would increase the likelihood of atrial fibrillation progression,” the authors said.

Investigators said there is an imperative to optimize medication utilization and explore the consequences of medication burden on treatment outcomes in patients with long COVID.

Researchers analyzed the impact of the COVID-19 pandemic on outcomes for patients with pancreatic cancer living in England.

Research has found that children and young adults with overweight or obesity may be at a significantly increased risk of developing long COVID.

A new study found that individuals who received a COVID-19 vaccine more recently were less likely to develop long COVID.